α-Pyrrolidinoheptaphenone
Chemical compound
From Wikipedia, the free encyclopedia
α-Pyrrolidinoheptaphenone (PV8, α-PEP, α-PHPP, Aphpp, A-PHPP) is a designer drug of the pyrrolidinophenone class of cathinones.[1][2] It is the higher homolog of α-pyrrolidinohexiophenone (α-PHP).
Other namesα-PHPP; alpha-PHPP; alpha-Pyrrolidinoheptiophenone; alpha-Pyrrolidinoheptanophenone; PV-8; PV8; Aphpp; A-PHPP
Legal status
- CA: Schedule I
- DE: NpSG (Industrial and scientific use only)
- UK: Class B
- US: Schedule I
CAS Number
- 13415-83-3
13415-55-9 (HCl)
2304915-38-4 (R)
2304915-72-6 (S)
| Clinical data | |
|---|---|
| Other names | α-PHPP; alpha-PHPP; alpha-Pyrrolidinoheptiophenone; alpha-Pyrrolidinoheptanophenone; PV-8; PV8; Aphpp; A-PHPP |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C17H25NO |
| Molar mass | 259.393 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
In the United States, α-pyrrolidinoheptaphenone is a Schedule I Controlled Substance.[3]